Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost/Timolol vs Latanoprost + Timolol in Glaucoma/OHT
NCT00293800Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2004
- Primary completion
- Dec 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing Travoprost/Timolol with Xalatan + Timolol (2 arms). Primary endpoint: Mean Intraocular Pressure (IOP) Change at 3 Months from Baseline. Started Jul 2004; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00293800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293800.